A Mixture of U.S. Food and Drug Administration–Approved Monoaminergic Drugs Protects the Retina From Light Damage in Diverse Models of Night Blindness

Henri Leinonen(University of Eastern Finland), Krzysztof Palczewski(University of California, Irvine)
Investigative Ophthalmology & Visual Science
April 4, 2019
Cited by 18


Related Papers